Table 3.
Percentage of resistant isolates from eyes with acute postoperative endophthalmitis. Period: 2010–2019
| Ciprofloxacin | Levofloxacin | Moxifloxacin | Oxacillin | Vancomycin | Gentamicin | Ceftazidime | Linezolid | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n (N) | %R | n (N) | %R | n (N) | %R | n (N) | %R | n (N) | %R | n (N) | %R | n (N) | %R | N (N) | %R | |
| Gram-positive | ||||||||||||||||
| Staphylococcus epidermidis (n = 17) | 13 (14) | 93 | 3 (3) | 100 | 6 (14) | 43 | 17 (17) | 100 | 0 (17) | 0 | 1 (17) | 6 | 17 (17)† | 100 | 0 (17) | 0 |
| Staphylococcus aureus (n = 4) | 0 (3) | 0 | 0 (1) | 0 | 0 (3) | 0 | 1 (4) | 25 | 0 (4) | 0 | 0 (4) | 0 | 1 (1)† | 100 | 0 (4) | 0 |
| Other Coagulase-negative Staphylococci* (n = 3) | 1 (3) | 33 | NT | 1 (3) | 33 | 2 (3) | 67 | 0 (3) | 0 | 0 (3) | 0 | 2 (3)† | 67 | 0 (3) | 0 | |
| Streptococcus pneumoniae (n = 2) | NT | 0 (2) | 0 | NT | NT | 0 (2) | 0 | NT | NT | NT | ||||||
| Streptococcus viridans (n = 2) | NT | NT | NT | NT | 0 (2) | 0 | NT | NT | NT | |||||||
| Enterococcus faecalis (n = 1) | NT | NT | NT | NT | 0 (1) | 0 | 0 (1) | 0 | NT | 0 (1) | 0 | |||||
| Gram-negative | ||||||||||||||||
| Klebsiella oxytoca (n = 1) | 0 (1) | 0 | NT | NT | NT | NT | 0 (1) | 0 | 0 (1) | 0 | NT | |||||
| Enterobacter cloacae (n = 1) | 0 (1) | 0 | NT | NT | NT | NT | 0 (1) | 0 | 0 (1) | 0 | NT | |||||
| Total | 14 (22) | 64 | 3 (6) | 50 | 7 (20) | 35 | 20 (24) | 83 | 0 (29) | 0 | 1 (27) | 4 | 20 (23) | 87 | 0 (25) | 0 |
n: number of resistant isolates; N: number of isolates tested; %R: percentage of resistant isolates; NT: not tested; *Staphylococcus lugdunensis and Staphylococcus haemolyticus; † For Staphylococcus spp., isolates resistant to oxacillin were considered resistant to cephalosporins